ReviveMed

Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees

Company overview

Headquarters	245 1st St, Cambridge, Massachusetts 02142, US
Websites	revivemed.io revive-med.com
NAICS	541714
SIC	873
Keywords	Precision Medicine, Systems Biology, Metabolomics, Precision Oncology, Artificial Intelligance
Employees	1-10
Socials

Key Contact at ReviveMed

Leila Pirhaji

Chief Executive Officer

ReviveMed Email Formats

ReviveMed uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@revivemed.io), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@revivemed.io	100%

About ReviveMed

ReviveMed, an MIT spinout, is an AI-driven metabolomics platform for precision medicine. Our patented technology detects 20x more metabolites per patient than traditional methods, enabling the creation of digital metabolic twins. Digital metabolic twins are virtual patient models representing individuals’ metabolic networks within a multi-omic context to simulate health and disease. We have a pipeline of metabolic twins for oncology and cardio-metabolic diseases, such as renal cell carcinoma, MASH, and obesity. Our metabolic twins increase trial success rates by predicting which patients respond to drugs and reducing trial sizes by simulating disease progression in placebo arms while providing mechanistic insights to prioritize and expand drug pipelines. We have several ongoing biopharma partnerships and have worked with 40% of the top-10 pharma.

ReviveMed revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding